ReviewExpert review of clinical pharmacology2021

Tocilizumab for the treatment of non-critical COVID-19 pneumonia: an overview of the rationale and clinical evidence to date.

Grace Kenny et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.